Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2056 to 2070 of 7682 results

  1. Palbociclib with trastuzumab and endocrine therapy for maintenance treatment of hormone-receptor positive, HER2-positive metastatic breast cancer [ID6251]

    Awaiting development [GID-TA11273] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  2. Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (MA review of TA781) [ID6287]

    In development [GID-TA11484] Expected publication date: 26 February 2025

    Technology appraisal guidance
    In development

  3. Pembrolizumab with chemotherapy for treating hormone receptor-positive HER2-negative locally recurrent inoperable or metastatic breast cancer [ID6285]

    Awaiting development [GID-TA11342] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  4. Subcutaneous ocrelizumab for treating primary progressive or relapsing multiple sclerosis TS ID 11895

      Status ...

    Technology appraisal guidance
    Topic selection

  5. The MIST Therapy system for the promotion of wound healing (MTG5)

    Evidence-based recommendations on the MIST Therapy system for the promotion of wound healing.

    Medical technologies guidance
    Published
    25 July 2011
    View recommendations

    Sections for MTG5

  6. SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver (DG5)

    Evidence-based recommendations on SonoVue (sulphur hexafluoride microbubbles) for contrast-enhanced ultrasound imaging of the liver

    Diagnostics guidance
    Published
    29 August 2012
    View recommendations

    Sections for DG5

  7. Ambulight PDT for the treatment of non-melanoma skin cancer (MTG6)

    Evidence-based recommendations on Ambulight PDT for the treatment of non-melanoma skin cancer.

    Medical technologies guidance
    Published
    25 July 2011
    View recommendations

    Sections for MTG6

  8. Spinal instrumentation with robot assisted navigation

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  9. Guselkumab for treating chronic plaque psoriasis in children aged 6 to 17 years TSID 12002

      Status ...

    Technology appraisal guidance
    Topic selection

  10. Atezolizumab with cabozantinib for treating metastatic non-small-cell lung cancer after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor TSID 11812

      Status ...

    Health technology evaluations
    Topic selection

  11. Transcatheter Tricuspid Valve Replacement

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  12. Selective internal radiation therapy for unresectable colorectal metastases in the liver

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  13. Extracorporeal shockwave therapy for refractory plantar fasciitis

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  14. Automated percutaneous mechanical lumbar discectomy

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  15. Miniature lens system implantation for advanced age-related macular degeneration

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection